Patient profiles, incidence and trends of lung cancer in Ethiopia from 2012 to 2023 using a cancer registry

利用癌症登记数据,分析2012年至2023年埃塞俄比亚肺癌患者概况、发病率和趋势。

阅读:5

Abstract

Lung cancer epidemiology varies widely across countries, yet local data remain scarce. This study analyzed 882 lung cancer cases registered in the Addis Ababa population-based cancer registry from 2012 to 2023 to characterize patient profiles, incidence rates, and trends. We used descriptive statistics, binary and multinomial logistic regression, Poisson regression, and joinpoint regression. We found the crude median age at diagnosis was 56 years (adjusted: 60 years), with one in four patients diagnosed before 45. Adenocarcinoma was the most common histological subtype (34.8%), significantly associated with females (AOR: 1.64, 95% CI: 1.21–2.21), followed by squamous cell carcinoma (8.8%). Carcinoma not otherwise specified (NOS) accounted for 45.2% of cases. Alarmingly, 93% of patients were diagnosed at a late stage. The age-standardized incidence rate (ASIR) was 3.1 per 100,000 (3.3 for males, 2.8 for females), with a male-to-female incidence rate ratio (IRR) of 1.13, showing a nonsignificant decline over time. The incidence rate increased with age and varied significantly across sub-cities (1.5–2.9 per 100,000). While the overall ASIR trend remained stable, sex-specific trends showed a 3% annual increase in female crude incidence rates, whereas male rates remained unchanged significantly. These findings highlight the urgent need for targeted lung cancer prevention, early detection, and treatment strategies tailored to local epidemiological patterns. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-36944-x.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。